Top Banner
QALYs and Ethics Prof. dr. Jan van Busschbach 1 1
23

QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Dec 22, 2015

Download

Documents

Gladys Pitts
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

QALYs and Ethics

Prof. dr. Jan van Busschbach

11

Page 2: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Health Economics

Comparing different allocations Should we spend our money on

• Wheel chairs• Screening for cancer

Comparing costs Comparing outcome

Outcomes must be comparable Make a generic outcome measure

2

Page 3: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Outcomes in health economics

Specific outcomes are incompatible Allow only for comparisons within the specific field

• Clinical successes: successful operation, total cure• Clinical failures: “events”

“Hart failure” versus “second psychosis”

Generic outcome are compatible Allow for comparisons between fields

• Life years• Quality of life

Most generic outcome Quality adjusted life year (QALY)

3

Page 4: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Example Blindness Time trade-off value is 0.5 Life span = 80 years 0.5 x 80 = 40 QALYs

Quality Adjusted Life Years (QALY)

4

0.00

1.00

X

Life years40 80

0.5 x 80 = 40 QALYs

Page 5: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Area under the curve

0 10 20 30 40 50 60 70 800

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

Co-morbidity

Psychotherapy

No psychotherapy

Life years

QA

LY

we

igh

ts

Page 6: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Cost per QALY

6

20 QALY gained €100.000 Cost per QALY

€100.000/20 QALYs = €5.000/QALY

Page 7: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

QALY league table

Intervention $ / QALYGM-CSF in elderly with leukemia 235,958

EPO in dialysis patients 139,623

Lung transplantation 100,957

End stage renal disease management 53,513

Heart transplantation 46,775

Didronel in osteoporosis 32,047

PTA with Stent 17,889

Breast cancer screening 5,147

Viagra 5,097

Treatment of congenital anorectal malformations 2,778

7

Page 8: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Ethical critics on QALY

8

Page 9: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

In the past, much criticism

Cohen CB. Quality of life and the analogy with the Nazis. Journal of Medicine and Philosophy 8: 113-35, 1983.

Page 10: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Criticism remains

….the strictly fascist essence of those QALYs (so-called Quality-

Adjusted Life Years)…

Page 11: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

11

10.915 QALY publications

0200400600800

100012001400

1970 1980 1990 2000 2010 2020

Pu

bli

cati

ons

1980[pdat] AND (QALY or QALYs)

Page 12: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

12

Three problems with the ethical criticism …..

1. Arguments represent aversion toward a limited budget2. Proposed alternatives turn out to be the same3. Even equity concerns are in need of QALY

Page 13: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1. Arguments often represent aversion limited budget

13

“…Wij hebben duidelijk aangegeven dat een discussie over "wat maatschappelijk nog aanvaardbaar is" [kosten per QALY] alleen gevoerd mag worden als geldverslindende "frivoliteiten" door de maatschappij […] zijn uitgebannen. Bijvoorbeeld "joint strike fighters“…

Kees van Bezooijen in his roll as Patient representative, 2007

Page 14: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

2. Proposed alternative turns out to be the same…

14

TWiST Time Without Symptoms of disease and

subjective Toxic effects of treatment

HYE Health Years Equivalent

SAVE Saved Young Life Equivalent

Capabilities Amartya Sen

DALY Disability Adjusted Life Years

Page 15: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1515

Burden of Disease Project

WHO Global Burden of Disease (GBD) Impact of diseases world wide Estimates of epidemiology per disease

Mortality Quality of life losses

In need of one measure of health But WHO disliked QALY…

Page 16: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1616

Chris Murray

Harvard School of Public Health

Worked outside Health economics Med Decision Making

DALY Disability Adjusted Life Years Lost life years Lost Quality of life

Page 17: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1717

DALY / QALY

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

0 10 20 30 40 50 60 70 80 90

Life years

Ad

jusm

ent

fact

or

DALY

QALY

Page 18: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1.0

0.0A B C

Kw

alit

eit

van

lev

en3. Equity

18

Efficiency

Equity

Page 19: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Is (should) burden (be) a criterion?

19

0

5

10

15

20

25

30

Accepted Rejected

High burden Low burden

Pronk & Bonsel, Eur J Health Econom 2004, 5: 274-277

Page 20: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

20

80

0A B C

Lev

ensj

aen

Costs/QALY as indicator of solidarity

20

60

40

20

€ 50.000

€ 30.000

€ 40.000

Page 21: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

Costs/QALY versus Burden of disease

21

€ 80.000

€ 60.000

€ 40.000

€ 20.000

€ 0

Burden of disease

X

XX

XX

Equity /

Burden

/ DALY

Page 22: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

22

Dutch Council for Public Health and Health Care (De Raad voor de Volksgezondheid en Zorg, 2006)

Page 23: QALYs and Ethics Prof. dr. Jan van Busschbach 11.

23

Three problems with the ethical criticism …..

1. Arguments represent aversion toward a limited budget2. Proposed alternatives turn out to be the same3. Even equity concerns are in need of QALY